1 – 15 of 18
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
(
- Contribution to journal › Article
- 2021
-
Mark
Mortality after Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders
(
- Contribution to journal › Article
-
Mark
Pharmacological Medical Treatment of Epilepsy in Patients with Dementia : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
General practitioners’ attitude toward early and pre-dementia diagnosis of ad in five European countries—a mopead project survey
(
- Contribution to journal › Article
- 2020
-
Mark
Secondary Stroke Prevention After Ischemic Stroke in Patients with Alzheimer's Disease and Other Dementia Disorders
(
- Contribution to journal › Article
-
Mark
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies
(
- Contribution to journal › Debate/Note/Editorial
- 2019
-
Mark
EuroInf 2 : Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
2019) In Movement Disorders(
- Contribution to journal › Article
- 2018
-
Mark
Stroke as a cause of death in death certificates of patients with dementia : A cohort study from the Swedish dementia registry
(
- Contribution to journal › Article
-
Mark
Acute Stroke Care in Dementia : A Cohort Study from the Swedish Dementia and Stroke Registries
(
- Contribution to journal › Article
- 2017
-
Mark
Management of acute ischaemic stroke in patients with dementia
(
- Contribution to journal › Scientific review
-
Mark
Thrombolysis in acute ischemic stroke in patients with dementia : A Swedish registry study
(
- Contribution to journal › Article
-
Mark
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort
(
- Contribution to journal › Article
-
Mark
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers
(
- Contribution to journal › Article
- 2016
-
Mark
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid Alzheimer's disease biomarkers across the spectrum of lewy body diseases : Results from a large multicenter cohort
(
- Contribution to journal › Article